Table of Contents
Conference Papers in Medicine
Volume 2013, Article ID 729850, 3 pages
http://dx.doi.org/10.1155/2013/729850
Conference Paper

New Aspects on Arterial Hypertension

Department of General and Interventional Cardiology, Hamburg University Heart Center, 20246 Hamburg, Germany

Received 15 January 2013; Accepted 1 April 2013

Academic Editors: A. Bellou, E. Giannitsis, C. Hamm, M. Möckel, and J. Searle

This Conference Paper is based on a presentation given by Stefan Blankenberg at “Clinical Decisions in Acute Patients: ACS–POCT–Hypertension and Biomarkers” held from 19 October 2012 to 20 October 2012 in Berlin, Germany.

Copyright © 2013 Johannes Tobias Neumann and Stefan Blankenberg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, “Global burden of hypertension: analysis of worldwide data,” The Lancet, vol. 365, no. 9455, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Greenberg, “MRC trial of treatment of mild hypertension: principal results,” British Medical Journal, vol. 291, no. 6488, pp. 97–104, 1985. View at Google Scholar · View at Scopus
  3. L. Liu, Y. Zhang, G. Liu, W. Li, X. Zhang, and A. Zanchetti, “The Felodipine Event Reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients,” Journal of Hypertension, vol. 23, no. 12, pp. 2157–2172, 2005. View at Google Scholar · View at Scopus
  4. J. N. Bella, V. Palmieri, M. J. Roman et al., “Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the strong heart study,” Circulation, vol. 105, no. 16, pp. 1928–1933, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Hansson, A. Zanchetti, S. G. Carruthers et al., “Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial,” The Lancet, vol. 351, no. 9118, pp. 1755–1762, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. N. S. Beckett, R. Peters, A. E. Fletcher et al., “Treatment of hypertension in patients 80 years of age or older,” The New England Journal of Medicine, vol. 358, no. 18, pp. 1887–1898, 2008. View at Google Scholar
  7. W. C. Cushman, G. W. Evans, R. P. Byington et al., “Effects of intensive blood-pressure control in type 2 diabetes mellitus,” The New England Journal of Medicine, vol. 362, no. 17, pp. 1575–1585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. F. C. Novello and J. M. Sprague, “Benzothiadiazine dioxides as novel diuretics,” Journal of the American Chemical Society, vol. 79, no. 8, pp. 2028–2029, 1957. View at Google Scholar · View at Scopus
  9. G. Mancia, G. De Backer, A. Dominiczak et al., “2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” European Heart Journal, vol. 28, no. 12, pp. 1462–1536, 2007. View at Google Scholar
  10. H. D. Sesso, J. E. Buring, M. J. Chown, P. M. Ridker, and J. M. Gaziano, “A prospective study of plasma lipid levels and hypertension in women,” Archives of Internal Medicine, vol. 165, no. 20, pp. 2420–2427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. H. D. Sesso, J. E. Buring, N. Rifai, G. J. Blake, J. M. Gaziano, and P. M. Ridker, “C-reactive protein and the risk of developing hypertension,” Journal of the American Medical Association, vol. 290, no. 22, pp. 2945–2951, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Wang, P. Gona, M. G. Larson et al., “Multiple biomarkers and the risk of incident hypertension,” Hypertension, vol. 49, no. 3, pp. 432–438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Krum, M. Schlaich, R. Whitbourn et al., “Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study,” The Lancet, vol. 373, no. 9671, pp. 1275–1281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Krum, “Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months,” Hypertension, vol. 57, no. 5, pp. 911–917, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. D. Esler, H. Krum, P. A. Sobotka et al., “Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial,” The Lancet, vol. 376, no. 9756, pp. 1903–1909, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Mahfoud, M. Schlaich, I. Kindermann et al., “Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study,” Circulation, vol. 123, no. 18, pp. 1940–1946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Brandt, S. Reda, F. Mahfoud, M. Lenski, M. Bohm, and U. C. Hoppe, “Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension,” Journal of the American College of Cardiology, vol. 60, no. 19, pp. 1956–1965, 2012. View at Google Scholar
  18. E. Pokushalov, A. Romanov, G. Corbucci et al., “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” Journal of the American College of Cardiology, vol. 60, no. 13, pp. 1163–1170, 2012. View at Google Scholar
  19. J. D. Bisognano, C. L. Kaufman, D. S. Bach, E. G. Lovett, and P. de Leeuw, “Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system,” Journal of the American College of Cardiology, vol. 57, no. 17, pp. 1787–1788, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Tissot, P. Maurer, J. Nussberger et al., “Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study,” The Lancet, vol. 371, no. 9615, pp. 821–827, 2008. View at Publisher · View at Google Scholar · View at Scopus